In a recent study that employed a microarray-based gene expression platform, we found that TGFB2 mRNA levels were selectively amplified in primary tumor samples from 29 pediatric DIPG patients compared to normal samples and primary tumor samples from low-grade glioma patients [39]. Here, TGFB2 is linked to diffuse intrinsic pontine glioma.